Guangdong Marubi Biotechnology Co., Ltd. Stock

Equities

603983

CNE100003M51

Personal Products

End-of-day quote Shanghai S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
30.05 CNY -1.48% Intraday chart for Guangdong Marubi Biotechnology Co., Ltd. -2.34% +18.92%
Sales 2024 * 2.93B 404M Sales 2025 * 3.52B 486M Capitalization 12.05B 1.66B
Net income 2024 * 371M 51.23M Net income 2025 * 462M 63.8M EV / Sales 2024 * 3.82 x
Net cash position 2024 * 855M 118M Net cash position 2025 * 875M 121M EV / Sales 2025 * 3.17 x
P/E ratio 2024 *
32.3 x
P/E ratio 2025 *
25.9 x
Employees 1,101
Yield 2024 *
0.99%
Yield 2025 *
1.15%
Free-Float 19.18%
More Fundamentals * Assessed data
Dynamic Chart
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Guangdong Marubi Biotechnology Co., Ltd.(XSSC:603983) added to S&P Global BMI Index CI
Guangdong Marubi Biotechnology Co., Ltd.(XSSC:603983) added to FTSE All-World Index CI
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Feijia Industrial Co., Ltd. announced that it expects to receive CNY 60 million in funding from Guangdong Marubi Biotechnology Co., Ltd. CI
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
More news
1 day-1.48%
1 week-2.34%
1 month-0.92%
3 months-5.50%
6 months+13.40%
Current year+18.92%
More quotes
1 week
29.81
Extreme 29.81
31.16
1 month
29.81
Extreme 29.81
33.81
Current year
25.01
Extreme 25.01
33.81
1 year
22.96
Extreme 22.96
35.25
3 years
19.10
Extreme 19.1
60.24
5 years
19.10
Extreme 19.1
92.89
10 years
19.10
Extreme 19.1
92.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 02-04-01
Director of Finance/CFO 53 05-12-31
Chief Tech/Sci/R&D Officer 41 19-03-31
Members of the board TitleAgeSince
Director/Board Member 58 23-05-22
Chief Executive Officer 55 02-04-01
Director of Finance/CFO 53 05-12-31
More insiders
Date Price Change Volume
24-05-31 30.05 -1.48% 1,150,100
24-05-30 30.5 +0.07% 1,677,849
24-05-29 30.48 -0.81% 1,015,800
24-05-28 30.73 -0.49% 946,050
24-05-27 30.88 +0.36% 906,200

End-of-day quote Shanghai S.E., May 30, 2024

More quotes
Guangdong Marubi Biotechnology Co., Ltd is a China-based company mainly engaged in development and manufacture, design, production and sales of various cosmetics, as well as the provision of related services. The Company's products mainly include eye care products, skin cleansing products, skin care products (cream lotion and mask), make-up products and others. The Company's brands mainly include Maru, Cac and Passional Lover. The Company mainly conducts its businesses in domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
30.05 CNY
Average target price
33.43 CNY
Spread / Average Target
+11.24%
Consensus
  1. Stock Market
  2. Equities
  3. 603983 Stock